首页> 外文期刊>Saudi Pharmaceutical Journal >Comparative in vitro dissolution study of carbamazepine immediate-release products using the USP paddles method and the flow-through cell system
【24h】

Comparative in vitro dissolution study of carbamazepine immediate-release products using the USP paddles method and the flow-through cell system

机译:使用USP桨法和流通池系统对卡马西平即释产品进行的体外溶出度比较研究

获取原文
           

摘要

Dissolution profiles of four carbamazepine immediate-release generic products (200mg tablets) and the reference product Tegretol(R) were evaluated using the USP paddles method and an alternative method with the flow-through cell system, USP Apparatus 4. Under official conditions all products met the Q specification, dissolution profiles of generic products were similar to the dissolution profile of the reference product (f"250) and model-independent parameters showed non significant differences to the reference product except mean dissolution time for product A (p0.05). On the other hand, when the flow-through cell system was used, none of the products met the pharmacopeial specification at 15min and product A did not reach dissolution criteria at 60min, dissolution profiles of all generic products were not similar to the reference product profile (f"250) and all model-independent parameters showed significant differences compared to the reference product (p0.05). Weibull's model was more useful for adjusting the dissolution data of all products in both USP apparatuses and Td values showed significant differences compared to the reference product (p0.05) when USP Apparatus 4 was used. These results indicate that the proposed method, using the flow-through cell system, is more discriminative in evaluating both, rate and extent of carbamazepine dissolution process from immediate-release generic products.
机译:使用USP桨法和流通池系统USP装置4的替代方法,评估了四种卡马西平即释通用产品(200毫克片剂)和参考产品Tegretol(R)的溶出曲线。在正式条件下,所有产品符合Q规范,通用产品的溶出曲线与参考产品的溶出曲线相似(f“ 2> 50),模型无关参数显示与参考产品无显着差异,但产品A的平均溶出时间(p < 0.05)。另一方面,当使用流通池系统时,没有一种产品在15分钟时达到药典规范,并且产品A在60分钟时未达到溶出度标准,所有通用产品的溶出度与参考产品资料(f“ 2 <50)和所有与模型无关的参数与参考产品相比均显示出显着差异(p <0.05)。 Weibull模型对于调整两种产品在USP仪器中的溶出度数据都更有用,当使用USP仪器4时,Td值与参考产品相比有显着差异(p <0.05)。这些结果表明,使用流通池系统的拟议方法在评价卡马西平从速释仿制药中的溶解过程的速率和程度方面更具判别力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号